Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Factor X Inhibitors

Factor X inhibitors belong to a chemical class of compounds that specifically target and inhibit the activity of factor X, also known as Stuart-Prower factor. Factor X is a crucial protein involved in the blood coagulation cascade, which is responsible for the formation of blood clots. The inhibitors act by interfering with the normal function of factor X, its role in the conversion of prothrombin to thrombin. Thrombin is essential for the final step in the clotting process, converting fibrinogen into fibrin, which forms the meshwork of a blood clot. The chemical structure of factor X inhibitors is designed to selectively bind to factor X, obstructing its active site or modulating its interactions with other proteins involved in the coagulation cascade. By inhibiting factor X, these compounds disrupt the clotting process and impede the formation of fibrin. This interference in the blood coagulation pathway can potentially have important implications in various contexts related to hemostasis and clotting disorders. As a class of compounds, factor X inhibitors are subject to ongoing research and development in the scientific community. Researchers aim to characterize their mechanisms of action, their specific interactions with factor X, and their potential impact on the clotting process. The ultimate goal of studying factor X inhibitors is to expand our understanding of the intricate mechanisms underlying blood coagulation, which could have implications in various fields of biology and biomedicine, though it is important to note that this description does not pertain to any or use of these compounds.

Items 11 to 16 of 16 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ecotin, E. coli

87928-05-0sc-221575
100 µg
$259.00
(0)

Ecotin, derived from E. coli, functions as a Factor X by exhibiting a high affinity for serine proteases, effectively blocking their activity. Its unique molecular architecture enables it to form stable complexes with target enzymes, disrupting their catalytic function. The compound showcases remarkable specificity and rapid binding kinetics, allowing for swift modulation of proteolytic pathways. This selective inhibition alters the dynamics of protein interactions, influencing various biological processes.

BMS-740808

280118-23-2sc-364445
sc-364445A
10 mg
50 mg
$480.00
$1455.00
(0)

BMS-740808 acts as a Factor X through its distinctive ability to selectively engage with specific protease active sites, leading to the formation of transient enzyme-inhibitor complexes. Its unique structural features facilitate precise molecular recognition, enhancing its interaction with target proteins. The compound demonstrates notable reaction kinetics, characterized by a rapid association and dissociation rate, which fine-tunes the modulation of enzymatic activity and influences downstream signaling pathways.

Fondaparinux

104993-28-4sc-507424
10 mg
$297.00
(0)

An indirect factor Xa inhibitor that indirectly inhibits factor Xa through its interaction with antithrombin III. It is used for prophylaxis of VTE.

Rivaroxaban-d4

1132681-38-9sc-219982
1 mg
$388.00
3
(0)

Rivaroxaban-d4 functions as a Factor X inhibitor by exhibiting a high affinity for the active site of the enzyme, disrupting the coagulation cascade. Its deuterated structure enhances stability and alters isotopic labeling, allowing for precise tracking in biochemical assays. The compound's unique binding dynamics promote a conformational change in the enzyme, effectively hindering its catalytic function. This specificity in molecular interaction underscores its role in modulating hemostatic processes.

Apixaban-13C, d3

1261393-15-0sc-480057
2.5 mg
$340.00
(0)

Apixaban-13C, d3 acts as a selective Factor X inhibitor, characterized by its unique isotopic labeling that facilitates advanced analytical techniques. Its distinct molecular interactions involve a strong binding affinity to the enzyme's active site, leading to a significant alteration in the enzyme's conformation. This compound exhibits unique reaction kinetics, allowing for a detailed understanding of coagulation pathways and enzyme regulation, making it a valuable tool for studying hemostatic mechanisms.

Warfarin

81-81-2sc-205888
sc-205888A
1 g
10 g
$72.00
$162.00
7
(1)

An anticoagulant that inhibits the synthesis of vitamin K-dependent clotting factors, including factor X. It has been widely used for many years for long-term anticoagulation in various conditions.